Modelling cancer in microfluidic human organs-on-chips
A Sontheimer-Phelps, BA Hassell, DE Ingber - Nature Reviews Cancer, 2019 - nature.com
One of the problems that has slowed the development and approval of new anticancer
therapies is the lack of preclinical models that can be used to identify key molecular, cellular …
therapies is the lack of preclinical models that can be used to identify key molecular, cellular …
[引用][C] Modelling cancer in microfluidic human organs-on-chips
A Sontheimer-Phelps, BA Hassell, DE Ingber - Nature Reviews Cancer, 2019 - cir.nii.ac.jp
Modelling cancer in microfluidic human organs-on-chips.
A Sontheimer-Phelps, BA Hassell… - Nature reviews …, 2019 - europepmc.org
One of the problems that has slowed the development and approval of new anticancer
therapies is the lack of preclinical models that can be used to identify key molecular, cellular …
therapies is the lack of preclinical models that can be used to identify key molecular, cellular …
Modelling cancer in microfluidic human organs-on-chips
A Sontheimer-Phelps, BA Hassell… - Nature reviews …, 2019 - pubmed.ncbi.nlm.nih.gov
One of the problems that has slowed the development and approval of new anticancer
therapies is the lack of preclinical models that can be used to identify key molecular, cellular …
therapies is the lack of preclinical models that can be used to identify key molecular, cellular …
Modelling cancer in microfluidic human organs-on-chips
A Sontheimer-Phelps, BA Hassell… - Nature Reviews Cancer, 2019 - go.gale.com
One of the problems that has slowed the development and approval of new anticancer
therapies is the lack of preclinical models that can be used to identify key molecular, cellular …
therapies is the lack of preclinical models that can be used to identify key molecular, cellular …